September 15, 2025
AbbVie Inc. has settled litigation with drug manufacturers, blocking generic versions of its immunosuppressant Rinvoq drug from the market for just over a decade and closing out litigation that accused generic-drug makers of infringing a slew of its patents.
April 11, 2025
AbbVie has settled a dispute accusing Sandoz of infringing multiple patents with its proposed generic versions of AbbVie's blockbuster immunosuppressant drug Rinvoq, according to a stipulation filed Friday in Delaware federal court.
November 21, 2023
AbbVie has lodged 136 patent infringement claims against Sandoz and a handful of other pharmaceutical companies, accusing them of infringing dozens of AbbVie's patents with their proposed generic versions of its blockbuster immunosuppressant Rinvoq, according to a suit filed in Delaware federal court.